Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pre-analytical characterization of CNS-derived extracellular vesicles from human saliva: effect of room temperature and cellular origin.

Frontiers in neuroscience·2026
Same author

Plasma p-tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS-HD.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

The Pfaffian Structure of CFN Phylogenetic Networks.

Journal of mathematical biology·2025
Same author

Routing Functions for Parameter Space Decomposition to Describe Stability Landscapes of Ecological Models.

Bulletin of mathematical biology·2025
Same author

Beyond Alzheimer's disease-translating biomarker insights across CNS diseases.

Science translational medicine·2025
Same author

Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Rejina Roufegarinejad1, Joseph Cummings2, Charisse N Winston3

  • 1University of San Diego, San Diego, CA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

代谢健康的超重/肥胖 (MHO) 黑人男性可能有阿尔茨海默氏病 (AD) 风险降低. 需要进一步的研究来证实MHO个体中的这些发现,重点是认知变化和生物标志物.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 老年学是指老年学的学科.
  • 公共卫生 公共卫生

背景情况:

  • 代谢和血管因素显著影响阿尔茨海默病 (AD) 风险,特别是在代谢不健康,超重/肥胖 (MUO) 个体中.
  • 阿尔茨海默病 (AD) 风险与代谢健康,超重/肥胖 (MHO) 状态之间的关联尚未得到充分理解.
  • 标准身体质量指数 (BMI) 衡量健康风险评估的指标显示种族和种族群体的变化,特别是黑人或非裔美国人.

研究的目的:

  • 研究黑人或非裔美国人体质指数 (BMI) /代谢概况与阿尔茨海默病 (AD) 风险之间的关系.
  • 探索代谢不健康 (MUO) 和代谢健康 (MHO) 个人资料以及黑人人口中神经退行和AD风险的生物标志物之间的相关性.
  • 解决当前BMI标准在评估不同种族群体健康风险方面的局限性.

主要方法:

  • 利用阿尔茨海默病神经成像计划 (ADNI) 队列的基线数据的多重线性回归模型.
  • 分析了MUO和MHO黑人个体的BMI和代谢概况.
  • 与神经退行和AD风险的生物标志物相关联,包括血生物标志物,大脑粉样β (Aβ) 负载和海马体积.

主要成果:

  • 在所有黑人参与者之间没有观察到BMI和认知状态的显著基线差异.
  • 初步分析表明,与MHO黑人女性相比,MHO黑人男性的BMI和认知状态之间存在非显著的正相关性,这表明AD风险可能降低.
  • 多变量线性回归模型将进一步探索MUO和MHO配置文件与关键AD生物标志物和神经成像数据的横截面关联.

结论:

  • 降低阿尔茨海默病 (AD) 风险可能与黑人男性的MHO状态有关.
  • 长度研究是必要的,以调查MHO个体的认知状态,Aβ和tau脑病理以及血生物标志物的变化.
  • 需要进一步的研究,以充分阐明不同人群中代谢健康,肥胖和AD风险之间的复杂相互作用.